An Oral-Fluid THC Meta-Analysis Separated Bivariate Associations From Adjusted Findings

A 2024 individual-participant meta-analysis found that some oral-fluid THC associations changed after statistical adjustment. Dose, use frequency and inhaled rather than ingested administration remained associated with higher concentrations, while some other associations appeared only in bivariate analyses.

The pooled data contained repeated observations

Seven controlled-administration studies contributed 1,157 observations. That is an observation count, not a count of 1,157 different participants. The analysis required individual concentration data at multiple time points and confirmatory measurements, which shaped the eligible evidence.

Adjustment narrowed the interpretation

Sex and a collection-device comparison were significant only in the reported bivariate analyses. Their disappearance from the adjusted findings limits an assertion of an independently demonstrated effect. It does not prove those variables never matter under other designs or conditions.

The concentration distributions were widely spread

Oral-fluid THC declined over time but remained dispersed and positively skewed at each time point. Most studies did not observe participants beyond 24 hours, while one documented later positives. These features limit using one concentration as an exact clock or impairment measure.

Interpreting the evidence

The useful inference preserves the model, variables and sampling schedule. An unadjusted association is not automatically an independent cause of a result. This synthesis does not supply a reliable reverse calculation of use time or a personal impairment threshold.

Related reading: interpreting cannabis tolerance claims.

Research reference

Scott Macdonald; Jinhui Zhao (2024). Concentrations of Delta 9-tetrahydrocannabinol (THC) in oral fluid at different time points after use: An individual participant meta-analysis. Heliyon. doi:10.1016/j.heliyon.2024.e39873.

This discussion draws on the abstract and introductory material in the supplied research synthesis.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

A 2021 pilot study reported strong initial antinociceptive responses to THC and cannabinolic acid, followed by decreasing responses over subsequent days. The evidence concerns adult male mice and experimental mechanical and thermal tests. The study evaluated two nociceptive domains Mechanical and thermal responses were assessed after systemic intraperitoneal administration. Those…

Spread the love

Read Article: A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A 2001 mouse study found different opioid- and cannabinoid-receptor protein patterns across midbrain and spinal cord after short-term THC–morphine treatment. A statement about total receptor change would obscure those tissue-specific comparisons. The comparison included separate treatment groups Investigators assessed THC, morphine and their combination using Western blot measurements. Opioid-receptor protein…

Spread the love

Read Article: Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

A 2003 study found that selected kinase inhibitors reversed THC antinociceptive tolerance while others did not. One higher-dose intervention reduced THC's acute antinociceptive effect, illustrating a different outcome from reversing tolerance. The panel included useful negatives The study tested interventions directed at several kinases. Some did not affect tolerance under…

Spread the love

Read Article: A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us